August 7, 2008
End of Transplant Drugs May Be Near
Germany scientists say they've created a technique that might avoid the necessity of transplant patients taking anti-rejection drugs the rest of their lives.
The researchers -- led by Professor Fred Fandrich at the University of Schleswig-Holstein in Kiel, Germany -- said their technique involves taking infection-fighting white cells from a transplant patient's blood and subjecting them to a highly complex procedure involving cells taken from the living or deceased donor. The tailor-made cells are then administered back to the patient.
"That is why our use of transplant acceptance-inducing cells in kidney transplant patients is such an exciting development, as it could eventually offer patients who have had transplant surgery a much higher quality of life, free from complex drug regimes."
The procedure is reported in the August issue of the journal Transplant International.